Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)

Label now includes Phase 3 clinical data evaluating the safety and efficacy of AVYCAZ (in combination with metronidazole) in patients with complicated intra-abdominal infections (cIAI) DUBLIN, June 23, 2016 -- (Healthcare Sales & Marketing Network) -- ... Biopharmaceuticals, FDAAllergan, AVYCAZ, ceftazidime, avibactam, cIAI
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news